TABLE 5.
Detection of intercurrent HIV infection by HIV Selectest among vaccine trial participants
| Vaccine trial | Vaccination status | n | HIV status | No. Selectest positive | % Selectest positive (95% CI) | Average % positive (95% CI) |
|---|---|---|---|---|---|---|
| VAX003/VAX004 | Placebo | 105 | Infected | 101 | 96.2 | 97.0 |
| Vaccine | 160 | Infected | 156 | 97.5 | ||
| HVTN204, South African arm | Placebo | NA | NA | NA | NA | 100 |
| Vaccine | 1 | Infected | 1 | 100 | ||
| HVTN203/HVTN039 | Placebo | 1 | Infected | 1 | 100 | 100 |
| Vaccine | 1 | Infected | 1 | 100 | ||
| Total | Placebo | 106 | Infected | 102 | 96.2 (90.6–99.0) | 97.0 (94.2–98.7) |
| Vaccine | 162 | Infected | 158 | 97.5 (93.8–99.0) |